Patent · US Active

Method for treating amyloid disease

US8906382B2 · kind B2 · utility

3Cited by
19References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 19, 2012
Grant dateDec 9, 2014
Priority date
Expiry dateJul 19, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/58
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to methods for treating human amyloid disease by administration of modified Aβ peptide immunogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.